Snyder Andrew Miles

Director Snyder buys 1,460,000 CLVT shares at $3.33, boosting stake 185.4% to 2.25M; stock down 46.4% from 52-week high, company unprofitable.

Andrew Miles Snyder (Director) purchased 1,460,000 shares at $3.33 on 2025-10-31, increasing his holdings by 185.4% from 787,510 to 2.25M shares at a total cost of $4,861,800.00. The purchase occurred when CLARIVATE's stock is down 46.4% from its 52-week high of $6.61 and the company is unprofitable (net income of $-28,300,000.00 on revenue of $623,100,000.00). His prior purchases at CLVT have shown mixed results: a March 2025 buy resulted in 30d -21.1%, a purchase on 2024-08-09 showed 30d +17.6%, and a 2024-08-08 buy showed 30d +21.5%. Across his broader trading history, his 3 prior buys average 90d return of -9.0% with a 33.33% win rate, and his CLVT timing pattern shows only 1 of 3 prior buys were well-timed at the 90-day mark, suggesting inconsistent execution even when purchasing at lower valuations.

Director Andrew Miles Snyder buys 237.2K CLVT shares at $4.17; holdings up 43.1% to 787.5K shares

Director Andrew Miles Snyder purchased 237,176 shares of Clarivate at $4.17 on 2025-03-14, increasing his holdings by 43.1% from 550,334 to 787,510 shares. The stock trades at $4.31 currently, down 12.0% over the past 30 days and down 43.7% from its 52-week high of $7.65. His prior two purchases at Clarivate in August 2024 showed mixed near-term results (30d returns of +17.6% and +21.5%) but both declined 90 days later (−17.5% and −12.6%), with a 0% win rate at the 90-day horizon for this ticker. Meanwhile, the company remains unprofitable with negative net income of −$65.6M on quarterly revenue of $622.2M, and has contracted annually by 2.7%. The sustained accumulation despite deteriorating fundamentals and persistent 90-day underperformance in his prior Clarivate purchases warrants tracking how conviction in this position is validated or contradicted by upcoming quarterly results and near-term price action.

Director Snyder Andrew Miles purchased 290,938 shares ($1,644,409.62) in 2 transactions at CLVT; holdings +112.2%, blended avg $5.65 vs current $5.51.

Director Snyder Andrew Miles made 2 separate purchases totaling 290,938 shares for $1,644,409.62, increasing his holdings by 112.2% from 259,396 to 550,334 shares. The blended average purchase price of $5.65 sits slightly above the current price of $5.51, and the stock has fallen -41.6% from its 52-week high of $9.44. This accumulation occurs within a context of material financial stress: the company reported a quarterly revenue of $650,300,000.00 but a net loss of $-304,300,000.00, with full-year results also unprofitable and annual revenue declining -1.2%. A director's significant personal investment at current market prices provides a tangible indicator of confidence in the intrinsic value proposition, though the timing coincides with the stock trading well below its recent range and the company reporting substantial losses.